Skip to content
Cover image for the PDSTEM neurology outlook

PDSTEM and the outlook for cell therapy in neurodegenerative disease

Why Parkinson's and dementia remain the hardest targets

Quick answer

PDSTEM is EHL Bio's pipeline cell drug aimed at Parkinson's disease. Neurodegeneration is hard because dead neurons do not regrow and therapies must cross the blood-brain barrier, so cell approaches focus on calming neuroinflammation and protecting surviving neurons rather than replacing lost ones.

Key facts

Product
PDSTEM
Indication
Parkinson's disease
Mechanistic goal
Neuroprotection, less inflammation
Clinical scale
UPDRS

Why lost dopamine neurons do not return

In Parkinson's, dopamine-producing neurons in the substantia nigra die off gradually, and tremor, rigidity and slowness appear only after substantial loss. Standard therapy such as levodopa controls symptoms well but does not halt the underlying degeneration.

Targeting the neuronal environment

Cell research instead tries to change the environment around neurons: dialling down overactive microglia, reducing oxidative stress and adding neurotrophic support. That is why trials measure clinical scales such as UPDRS alongside long follow-up windows.

Three questions before deciding

For Thai families the blunt advice is to expect no cure and to always ask three things: what research stage the product is at, what outcome measure is used, and what follow-up is planned. This disease group attracts the most overstated marketing.

Frequently asked questions

  • Do stem cells regrow neurons?

    The MSCs used clinically generally do not become neurons; they act through secreted factors that reduce inflammation and protect existing cells.

  • Should Parkinson's medication be stopped?

    Never stop on your own; only a neurologist should adjust the regimen.

  • What is PDSTEM and the outlook for cell therapy in neurodegenerative disease?

    PDSTEM is EHL Bio's pipeline cell drug aimed at Parkinson's disease. Neurodegeneration is hard because dead neurons do not regrow and therapies must cross the blood-brain barrier, so cell approaches focus on calming neuroinflammation and protecting surviving neurons rather than replacing lost ones.

  • PDSTEM and the outlook for cell therapy in neurodegenerative disease: what is the product?

    Product: PDSTEM

Medical cautions

5 points • reviewed 2026-08-28

Expand
  • This article is educational information only — not a diagnosis, prescription, or personal medical advice.
  • Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
  • Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
  • Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
  • Prices, packages, and service details can change — confirm directly with the provider before paying.

Reviewed and last updated: 2026-08-28

References and sources

10 sources • every claim is traceable

Expand
  1. 1. EHL Bio — company introduction

    https://www.ehlbio.co.kr/company/about/

  2. 2. EHL Bio — company history

    https://www.ehlbio.co.kr/company/history/

  3. 3. EHL Bio — GMP centre

    https://www.ehlbio.co.kr/rd/gmp/

  4. 4. EHL Bio — stem cell therapeutics pipeline

    https://www.ehlbio.co.kr/rd/institute/

  5. 5. EHL Bio — patents and research papers

    https://www.ehlbio.co.kr/rd/patent/

  6. 6. EHL Bio — EHL-STEM conditioned media

    https://www.ehlbio.co.kr/conditioned/

  7. 7. EHL Bio — immune cells

    https://www.ehlbio.co.kr/immune_cell/

  8. 8. EHL Bio — target diseases

    https://www.ehlbio.co.kr/cure/index/

  9. 9. EHL Bio — locations and contact

    https://www.ehlbio.co.kr/company/contact/

  10. 10. Original article on khunkim.com (pre-migration)

    https://www.ehlbio.co.kr

Browse the full reference library →

Share this page

Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories
See all articles

Related topics: Cell drug pipeline · Brain & nerves

See all in this category